Alector, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Alector, Inc. (ALEC) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$22.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- Alector, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$22.00K.
- Alector, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$270.00K.
- Alector, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $101.00K, a 93.49% decline year-over-year.
- Alector, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was -$95.00K.
- Alector, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$95.00K, a 223.38% decline from fiscal 2024.
- Alector, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $77.00K, a 98.38% decline from fiscal 2023.
- Alector, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $4.76M.
- Alector, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$3.63M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$22.00K 10-Q · filed 2026-08-06 | -$292.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$270.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | -$95.00K 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $101.00K 10-Q · filed 2025-11-06 | $6.00K derived: sum of 2 quarters · filed 2026-08-06 | -$64.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$95.00K 10-Q · filed 2026-08-06 | -$165.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$70.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $77.00K 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $1.55M 10-Q · filed 2025-11-06 | $1.33M derived: sum of 2 quarters · filed 2025-11-06 | $747.00K derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$217.00K 10-Q · filed 2025-11-06 | -$804.00K derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | -$587.00K 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $4.76M 10-K · filed 2025-02-26 | |||
| 2023-09-30 | $665.00K 10-Q · filed 2024-11-06 | $1.48M derived: sum of 2 quarters · filed 2024-11-06 | $3.85M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $813.00K 10-Q · filed 2024-11-06 | $3.19M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $2.38M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | -$3.63M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$518.00K 10-Q · filed 2023-11-07 | -$2.81M derived: sum of 2 quarters · filed 2023-11-07 | -$5.80M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$2.29M 10-Q · filed 2023-11-07 | -$5.28M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | -$2.99M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | -$1.56M 10-K · filed 2024-02-27 | |||
| 2021-09-30 | -$244.00K 10-Q · filed 2022-11-08 | -$451.00K derived: sum of 2 quarters · filed 2022-11-08 | -$655.00K derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | -$207.00K 10-Q · filed 2022-11-08 | -$411.00K derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | -$204.00K 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $472.00K 10-K · filed 2023-02-28 | |||
| 2020-09-30 | -$752.00K 10-Q · filed 2021-11-04 | -$1.69M derived: sum of 2 quarters · filed 2021-11-04 | $952.00K derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | -$936.00K 10-Q · filed 2021-11-04 | $1.70M derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $2.64M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $184.00K 10-K · filed 2022-02-24 | |||
| 2019-09-30 | -$215.00K 10-Q · filed 2020-11-10 | $118.00K derived: sum of 2 quarters · filed 2020-11-10 | $268.00K derived: sum of 3 quarters · filed 2020-11-10 | |
| 2019-06-30 | $333.00K 10-Q · filed 2020-11-10 | $483.00K derived: sum of 2 quarters · filed 2020-11-10 | ||
| 2019-03-31 | $150.00K 10-Q · filed 2020-11-10 | |||
| 2018-12-31 | -$42.00K 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$48.00K 10-Q · filed 2019-11-12 | $14.00K derived: sum of 2 quarters · filed 2019-11-12 | -$140.00K derived: sum of 3 quarters · filed 2019-11-12 | |
| 2018-06-30 | $62.00K 10-Q · filed 2019-11-12 | -$92.00K derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2018-03-31 | -$154.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |